Annual report [Section 13 and 15(d), not S-K Item 405]

Marketable Securities

v3.26.1
Marketable Securities
12 Months Ended
Dec. 31, 2025
Investments, All Other Investments [Abstract]  
Marketable Securities

Note 5: Marketable Securities

 

The Company classifies and accounts for its marketable debt securities as AFS and the securities are stated at fair value in accordance with ASC 326, Financial Instruments - Credit Losses.

 

The investments in marketable securities had an adjusted cost basis of $4 million and a market value of $4 million as of December 31, 2025. The balances consisted of the following securities (in thousands):

                       
    Amortized Cost     Unrealized Gain/(Loss)     Fair Value  
U.S. Treasury   $ 3,953     $ 25     $ 3,978  
Total   $ 3,953     $ 25     $ 3,978  

 

The investments in marketable securities as of December 31, 2024 had an amortized cost basis of $2.1 million and a market value of $2.0 million. The balances consisted of the following securities (in thousands):

 

    Amortized Cost     Unrealized Gain/(Loss)     Fair Value  
Corporate Bonds   $ 559     $ (22 )   $ 537  
U.S. Agency and Government Sponsored Securities     1,155       (48 )     1,107  
U.S. States and Municipalities     402       (17 )     385  
Total   $ 2,116     $ (87 )   $ 2,029  

 

The Company holds two AFS securities, all of which were in an unrealized gain position and none had been in an unrealized loss position for a period longer than 12 months as of December 31, 2025. The AFS securities held by the Company as of December 31, 2024 had been in an unrealized loss position for a period greater than 12 months. The Company reported the net unrealized losses in accumulated other comprehensive loss, a component of stockholders’ equity. As of December 31, 2025 and December 31, 2024, an allowance for credit loss was not recognized as the issuers of the securities had not established a cause for default, various rating agencies had reaffirmed each security's investment grade status and the Company did not have the intent, nor is it required to sell its securities prior to recovery.

 

Realized losses of $36,674 and $0.6 million were recognized in earnings during the years ended December 31, 2025 and December 31, 2024, respectively, primarily due to selling securities prior to maturity to prevent further market condition losses on the securities.

 

The contractual maturities of the Company’s marketable investments as of December 31, 2025 were as follows (in thousands):

       
    Fair Value  
Due within 1 year   $ 3,978  
Total   $ 3,978  

 

The Company may sell certain of its marketable debt securities prior to their stated maturities for reasons including, but not limited to, managing liquidity, credit risk, duration and asset allocation.